Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Bolt Biotherapeutics Inc logo

Bolt Biotherapeutics Inc

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

0.92
 
USD
  
-0.01
  
(-0.96%)
Optionable: No  Market Cap: 33 M  90-day average vol: 113,623

Previous close: 0.9299  Open: 0.931  Bid: 0.91  Ask: 0.96
52 week range    
0.86   
   2.03
Peers   
NR / 
NOV / 
FTI / 
GEOS / 
DRQ / 
FTK / 
Last updated: Wednesday 29th November 2023
33
MarketXLS Rank
40
Value
23
Technical
36
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

DRQ

1 B-11.824.37

FTI

3 B23.26.76

FTK

0 B-1.80.844

GEOS

0 B-8.35.53

NOV

0.01267 B-11.315.91

NR

0 B-8.13.66

OIS

0 B-66.56
Financials

BOLT Income Statement

Annual
Invalid dateDec-21Dec-22
Basic EPS from continuing operations-2.97
Basic EPS total-2.97-2.36
Basic weighted shares outstanding33 M37 M
Depreciation-1 M-2 M
DepreciationAndAmortization-1 M-2 M
Diluted EPS total-2.97-2.36
Diluted normalized net income/share-2.97
Diluted weighted shares outstanding33 M37 M
GeneralAndAdministrativeExpense18 M23 M
Gross operating profit1 M6 M
Income before tax-99 M-88 M
Interest income-6 M
Net income from total operations-99 M-88 M
NetIncomeCommonStockholders-99 M-88 M
NetIncomeContinuousOperations-99 M-88 M
NetNonOperatingInterestIncomeExpense-6 M2 M
Operating income-93 M-90 M
Operating income before depreciation (EBITDA)-92 M-83 M
OperatingExpense94 M-96 M
OtherGandA18 M23 M
OtherOperatingExpenses-7 M-6 M
RentAndLandingFees23 M
Research & development expense76 M73 M
ResearchExpense76 M73 M
SalariesAndWages-8 M-10 M
Selling Gen & administrative expense18 M23 M
Total Income available for interest expense (EBIT)-99 M-88 M
Total common shares outstanding37 M38 M
Total net income-99 M-88 M
Total ordinary shares38 M38 M
Total revenues1 M6 M
TotalExpenses94 M-96 M
TotalRevenue1 M6 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today